This page shows Oaktree Specialty (OCSL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Oaktree Specialty passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
For every $1 of reported earnings, Oaktree Specialty generates $6.73 in operating cash flow ($228.4M OCF vs $33.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Oaktree Specialty reported $33.9M in net income in fiscal year 2025. This represents a decrease of 41.4% from the prior year.
Oaktree Specialty earned $0.39 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 45.8% from the prior year.
Oaktree Specialty held $79.6M in cash against $1.5B in long-term debt as of fiscal year 2025.
Oaktree Specialty had 88M shares outstanding in fiscal year 2025. This represents an increase of 7.1% from the prior year.
Oaktree Specialty's ROE was 2.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.6 percentage points from the prior year.
Oaktree Specialty spent $10.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 587.7% from the prior year.
OCSL Income Statement
| Metric | Q1'26 | Q3'25 | Q2'25 | Q3'24 | Q1'25 | Q3'23 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $841K-15.6% | $997K+6.4% | $937K+24.6% | $752K+27.2% | $591K-27.1% | $811K-35.4% | $1.3M+68.2% | $746K |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $26.7M-14.2% | $31.1M+10.2% | $28.2M-8.4% | $30.8M-4.3% | $32.2M+171.0% | $11.9M-57.3% | $27.8M+34.2% | $20.7M |
| Income Tax | N/A | $1.0M | N/A | -$1.0M | N/A | N/A | N/A | N/A |
| Net Income | $5.6M-85.4% | $38.4M+205.8% | -$36.2M-198.8% | $36.7M+248.2% | $10.5M+127.8% | -$37.8M-275.8% | $21.5M+63.4% | $13.2M |
| EPS (Diluted) | $0.06-86.4% | $0.44+204.8% | $-0.42-187.5% | $0.48+242.9% | $0.14+122.6% | $-0.62-313.8% | $0.29+31.8% | $0.22 |
OCSL Balance Sheet
| Metric | Q1'26 | Q3'25 | Q2'25 | Q3'24 | Q1'25 | Q3'23 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.1B+4.5% | $3.0B-3.7% | $3.1B-3.7% | $3.2B-2.1% | $3.3B+1.5% | $3.2B-3.0% | $3.3B+19.9% | $2.8B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $80.8M+1.3% | $79.8M-18.4% | $97.8M+53.0% | $64.0M-43.1% | $112.4M-17.6% | $136.4M+211.9% | $43.8M+151.7% | $17.4M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.7B+11.7% | $1.5B-7.3% | $1.6B-6.2% | $1.7B-2.5% | $1.8B+3.1% | $1.7B-5.6% | $1.8B+15.2% | $1.6B |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $1.6B+11.2% | $1.4B-0.1% | $1.4B-11.6% | $1.6B+1.0% | $1.6B+1.4% | $1.6B-7.1% | $1.7B+17.8% | $1.5B |
| Total Equity | $1.4B-2.7% | $1.5B+0.1% | $1.5B-0.9% | $1.5B-1.6% | $1.5B-0.3% | $1.5B0.0% | $1.5B+26.1% | $1.2B |
| Retained Earnings | -$914.8M-2.6% | -$891.7M+0.2% | -$893.1M-14.9% | -$777.5M-12.7% | -$689.7M-5.9% | -$651.3M-0.3% | -$649.1M-3.3% | -$628.3M |
OCSL Cash Flow Statement
| Metric | Q1'26 | Q3'25 | Q2'25 | Q3'24 | Q1'25 | Q3'23 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$83.5M-495.9% | $21.1M-66.0% | $62.0M-35.1% | $95.5M+8389.7% | $1.1M-99.5% | $243.8M+427.9% | $46.2M+142.0% | -$109.9M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $84.8M+263.5% | -$51.8M+36.8% | -$82.0M+34.5% | -$125.2M-755.0% | -$14.6M+91.5% | -$171.4M-1277.1% | -$12.4M-112.1% | $103.3M |
| Dividends Paid | $34.1M+2.6% | $33.2M-10.4% | $37.1M-15.0% | $43.7M-7.0% | $47.0M+14.7% | $40.9M-0.4% | $41.1M-27.6% | $56.7M |
| Share Buybacks | $1.1M-69.7% | $3.8M-12.5% | $4.3M+176.5% | $1.6M | $0 | $0 | N/A | N/A |
OCSL Financial Ratios
| Metric | Q1'26 | Q3'25 | Q2'25 | Q3'24 | Q1'25 | Q3'23 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 339.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 0.4%-2.2pp | 2.6%+2.0pp | 0.6%-1.8pp | 2.4%+1.7pp | 0.7% | N/A | 1.4%+0.3pp | 1.1% |
| Return on Assets | 0.2%-1.1pp | 1.3%+2.5pp | -1.2%-2.3pp | 1.1%+0.8pp | 0.3% | N/A | 0.7%+0.2pp | 0.5% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 1.12+0.1 | 0.980.0 | 0.98-0.1 | 1.10+0.0 | 1.07+0.0 | 1.06-0.1 | 1.14-0.1 | 1.22 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Oaktree Specialty profitable?
Yes, Oaktree Specialty (OCSL) reported a net income of $33.9M in fiscal year 2025.
What is Oaktree Specialty's earnings per share (EPS)?
Oaktree Specialty (OCSL) reported diluted earnings per share of $0.39 for fiscal year 2025. This represents a -45.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Oaktree Specialty have?
As of fiscal year 2025, Oaktree Specialty (OCSL) had $79.6M in cash and equivalents against $1.5B in long-term debt.
What is Oaktree Specialty's return on equity (ROE)?
Oaktree Specialty (OCSL) has a return on equity of 2.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Oaktree Specialty's operating cash flow?
Oaktree Specialty (OCSL) generated $228.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Oaktree Specialty's total assets?
Oaktree Specialty (OCSL) had $3.0B in total assets as of fiscal year 2025, including both current and long-term assets.
Does Oaktree Specialty buy back shares?
Yes, Oaktree Specialty (OCSL) spent $10.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Oaktree Specialty have outstanding?
Oaktree Specialty (OCSL) had 88M shares outstanding as of fiscal year 2025.
What is Oaktree Specialty's debt-to-equity ratio?
Oaktree Specialty (OCSL) had a debt-to-equity ratio of 1.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Oaktree Specialty's return on assets (ROA)?
Oaktree Specialty (OCSL) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Oaktree Specialty's Piotroski F-Score?
Oaktree Specialty (OCSL) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Oaktree Specialty's earnings high quality?
Oaktree Specialty (OCSL) has an earnings quality ratio of 6.73x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.